Key result
Macrophage-specific NLRP3 deficiency significantly attenuated aortic fibrosis and improved left ventricular diastolic dysfunction in a mouse model of HFpEF.
Why the study?
Aortic stiffness from fibrosis is common in HFpEF and contributes to LV diastolic dysfunction, but the underlying inflammatory mechanism remains to be investigated.
Does macrophage-specific NLRP3 deficiency improve aortic fibrosis and LV diastolic dysfunction in a mouse model of HFpEF?
Does macrophage-specific NLRP3 deficiency improve aortic fibrosis and LV diastolic dysfunction in a mouse model of HFpEF?
Inhibition of macrophage NLRP3 inflammasome-dependent IL-1β production attenuates aortic fibrosis and cardiac diastolic dysfunction in a mouse model of HFpEF, suggesting a potential therapeutic target.
Novel mouse model links inflammation to aortic fibrosis in HFpEF; leaves open translation to human diastolic dysfunction.
Fibrosis is the main pathological feature of aortic stiffness, which is a common extracardiac comorbidity of heart failure with preserved ejection fraction (HFpEF) and a contributor to left ventricular (LV) diastolic dysfunction. Systemic low-grade inflammation plays a crucial role in the pathogenesis of HFpEF and the development of vascular fibrosis. In this study, we investigate the inflammatory mechanism of aortic fibrosis in HFpEF using a novel mouse model. LV diastolic dysfunction with preserved ejection fraction and aortic fibrosis induced by a high-fat diet (HFD) combined with subcutaneous aldosterone infusion are utilized. The constructed model exhibits augmented macrophage recruitment and NLR family pyrin domain containing 3 (NLRP3)-dependent interleukin (IL)-1β production in fibrotic aortas. In addition, a bone marrow transplant is employed to induce macrophage-specific NLRP3 deficiency in the HFpEF mouse model. These mice show almost completely suppressed cleaved-caspase-1 and mature IL-1β protein expression in the aortas, indicating that macrophage NLRP3 inflammasome activation enhances the IL-1β overproduction in fibrotic aortas. Furthermore, we show that macrophage NLRP3 inflammasome inhibition improves aortic fibrosis and LV diastolic dysfunction. In conclusion, this study demonstrates the pivotal effect of macrophage NLRP3-dependent IL-1β production on aortic fibrosis and cardiac function in HFpEF, suggesting a potential target for HFpEF therapy.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied Heart failure with preserved ejection fraction (HFpEF) and aortic fibrosis. Macrophage-specific NLRP3 deficiency vs. Wild-type bone marrow transplant (H11-G/R BM) was evaluated on Aortic fibrosis and LV diastolic dysfunction. Macrophage-specific NLRP3 deficiency significantly attenuated aortic fibrosis and improved left ventricular diastolic dysfunction in a mouse model of HFpEF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: